New avenues for brain repair poster

In recent years, significant advancements in brain repair have been made, particularly by exploring cellular reprogramming techniques. These methods promise to treat neurological disorders and injuries by replacing injured and necrotic neuronal tissue and restoring the normal functioning of neurons.

Our New Avenues from Brain Repair poster explores key areas, including reprogramming somatic cells into neurons and glia via a pluripotent intermediate stage, direct lineage reprogramming of somatic cells into neurons, lineage reprogramming in vivo, and the role of adult neurogenesis in integrating new neurons into existing neuronal networks.

Download our new avenues for brain repair poster

One of the pioneering approaches in brain repair involves reprogramming somatic cells into induced pluripotent stem cells (iPSCs), which can then be differentiated into neurons and glial cells. This method, first demonstrated by Takahashi and Yamanaka in 2006, involves introducing specific transcription factors (Oct4, Sox2, Klf4, and c-Myc) into somatic cells, such as fibroblasts, to revert them to a pluripotent state¹. These iPSCs can then be guided to differentiate into various neural cell types, including neurons and glia, by applying specific growth factors and signaling molecules. The advantage of this approach is that it can generate a virtually unlimited supply of patient-specific neural cells. These cells can be used for disease modeling, drug screening, and potential cell replacement therapies. However, there are still challenges to overcome, including the risk of tumor formation due to the pluripotent nature of iPSCs and the complexity of precisely controlling their differentiation.

Direct lineage reprogramming bypasses the pluripotent intermediate stage by converting somatic cells directly into neurons. This process includes the overexpression of neuron-specific transcription factors, such as Ascl1, Brn2, and Myt1l, which can induce a neuronal fate in cells like fibroblasts³. This method has produced functional neurons capable of forming synapses and exhibiting electrophysiological properties characteristic of mature neurons. Nevertheless, the efficiency of reprogramming and the functional integration of these neurons into existing neural circuits remain areas of ongoing research.

In vivo lineage reprogramming directly converts resident glial cells, such as astrocytes or NG2-glia, into neurons within the brain. This technique employs the natural plasticity of glial cells, enabling them to respond to injury or disease by re-entering the cell cycle and adopting new roles. By introducing specific transcription factors or small molecules directly into the brain, researchers have successfully reprogrammed glial cells into functional neurons in animal models⁴. In vivo reprogramming holds significant therapeutic potential as it allows for generating new neurons at the site of injury or degeneration, potentially restoring lost functions, avoiding cell transplantation, and reducing the risk of immune rejection or other complications. However, challenges such as ensuring the precise targeting and controlled reprogramming of glial cells and the long-term survival and integration of newly generated neurons need to be addressed⁵.

Understanding the mechanisms regulating adult neurogenesis is crucial for developing strategies to enhance brain repair and integrate new neurons into existing networks. Newly generated neurons in the adult brain undergo a series of stages, including proliferation, differentiation, migration, and integration into existing circuits. Neurotrophic support, synaptic activity, and the local microenvironment are critical in these processes. Enhancing adult neurogenesis through pharmacological or genetic interventions has shown promise in improving cognitive functions and promoting recovery in animal models of neurological diseases. Moreover, insights gained from studying adult neurogenesis can inform strategies for integrating reprogrammed neurons into the brain. For example, understanding how new neurons establish synaptic connections and become functionally integrated can guide the development of protocols to enhance the survival and integration of transplanted or in vivo reprogrammed neurons.

Exploring new avenues for brain repair through cellular reprogramming presents significant potential for treating neurological disorders and injuries. Although considerable difficulties still exist, active research enhances our understanding of these processes and brings us closer to effective therapies. Our pathway poster provides an overview of recent advances in this field. It showcases current methodologies for neuronal reprogramming from somatic cells or glia and strategies for integrating these emerging neurons into the existing neuronal network.

References

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

2. Robinson, M., McKee-Reed, O., Letwin, K. & Willerth, S. M. Direct Reprogramming Somatic Cells into Functional Neurons: A New Approach to Engineering  Neural Tissue In Vitro and In Vivo. In Regenerative Medicine and Plastic Surgery (eds Duscher, D. & Shiffman, M. A.) (Springer, Cham, 2019).

3. Leaman, S., Marichal, N. & Berninger, B. Reprogramming cellular identity in vivo.  Development  149, dev200433 (2022).

4. Mertens, J., Marchetto, M. C., Bardy, C. & Gage, F. H. Evaluating cell reprogramming, differentiation, and conversion technologies in neuroscience.  Nat. Rev. Neurosci.  17, 424–437 (2016).

5. Whalley, K. Encouraging integration.  Nat. Rev. Neurosci.  17, 669 (2016).